Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
Personalis, Inc. (PSNL) to Present at Needham Virtual Healthcare Conference
03/28/2024 - 04:01 PM
FREMONT, Calif. --(BUSINESS WIRE)--
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time.
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California . To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter ).
View source version on businesswire.com: https://www.businesswire.com/news/home/20240328562554/en/
Investors:
investors@personalis.com
Media:
pr@personalis.com
Source: Personalis, Inc.
When will Personalis, Inc. (PSNL) present at the 23rd Annual Needham Virtual Healthcare Conference?
Personalis, Inc. (PSNL) will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10 at 1:30 p.m. Eastern Time.
PSNL Rankings
#4996 Ranked by Stock Gains
PSNL Stock Data
Industry
Medical Laboratories
Sector
Health Care and Social Assistance
Tags
Biotechnology, Health Technology, Health Care and Social Assistance, Medical Laboratories
Country
US
City
Menlo Park
About PSNL
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
